Fan Zhe, Zhuang Chengjun, Wang Shuang, Zhang Yewei
Department of General Surgery, the Third People's Hospital of Dalian, Dalian Medical University, Dalian, China.
Department of Central Laboratory, the Third People's Hospital of Dalian, Dalian Medical University, Dalian, China.
Front Oncol. 2021 Dec 7;11:787780. doi: 10.3389/fonc.2021.787780. eCollection 2021.
Hepatocellular carcinoma (HCC) is the most common primary liver tumor. It is ranked the sixth most common neoplasm and the third most common cause of cancer mortality. At present, the most common treatment for HCC is surgery, but the 5-year recurrence rates are still high. Patients with early stage HCC with few nodules can be treated with resection or radiofrequency ablation (RFA); while for multinodular HCC, transarterial chemoembolization (TACE) has been the first-line treatment. In recent years, based on medical engineering cooperation, nanotechnology has been increasingly applied to the treatment of cancer. Photodynamic therapy and photothermal therapy are effective for cancer. This paper summarizes the latest progress of photodynamic therapy and photothermal therapy for HCC, with the aim of providing new ideas for the treatment of HCC.
肝细胞癌(HCC)是最常见的原发性肝脏肿瘤。它在最常见的肿瘤中排名第六,是癌症死亡的第三大常见原因。目前,HCC最常见的治疗方法是手术,但5年复发率仍然很高。早期结节较少的HCC患者可采用切除或射频消融(RFA)治疗;而对于多结节HCC,经动脉化疗栓塞(TACE)一直是一线治疗方法。近年来,基于医学工程合作,纳米技术越来越多地应用于癌症治疗。光动力疗法和光热疗法对癌症有效。本文总结了光动力疗法和光热疗法治疗HCC的最新进展,旨在为HCC的治疗提供新思路。